DR. Gail Smith Westhoven, M.D. is a dermatology in Birmingham, AL with 29 years of experience. The provider is a dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging. DR. Gail Smith Westhoven, M.D. NPI is 1528054319. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a female.
Education
Medical School: UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE
Graduation Year:1995
The provider's business location address is:
1401 EDWARDS LAKE RD.
BIRMINGHAM, AL
ZIP 35235
Phone: (205) 853-3960
Fax: (205) 853-3966
The NPI 1528054319 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Destruction of 2-14 skin growths (HCPCS:17003)
- Destruction of skin growth (HCPCS:17000)
- Biopsy of single growth of skin and/or tissue (HCPCS:11100)
- Biopsy of each additional growth of skin and/or tissue (HCPCS:11101)
- Destruction of up to 14 skin growths (HCPCS:17110)
- Removal of malignant growth (1.1 to 2.0 centimeters) of the face, ears, eyelids, nose, or lips (HCPCS:11642)
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- Injection beneath the skin or into muscle for therapy, diagnosis, or prevention (HCPCS:96372)
- Injection, dexamethasone sodium phosphate, 1mg (HCPCS:J1100)
The enumeration date for this NPI number is 9/27/2005 and was last updated on 3/10/2014.